External-beam radiotherapy for pediatric and young adult desmoid tumors

Pediatric Blood and Cancer

Volumn 57, Issue 3, 2011, Pages 435-442

  Rutenberg, Michael S ^a   Indelicato, Daniel J ^a,b   Knapik, Jacquelyn A ^a   Lagmay, Joanne P ^a   Morris, Christopher ^a   Zlotecki, Robert A ^a   Scarborough, Mark T ^a   Gibbs, Charles P ^a   Marcus, Robert B ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aggressive fibromatosis; Desmoid; Pediatric; Radiation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELLULITIS; CHILD; CLINICAL ARTICLE; DESMOID TUMOR; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LYMPHEDEMA; NEUROPATHIC JOINT DISEASE; OSTEOMYELITIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PATHOLOGIC FRACTURE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SCHOOL CHILD; SKIN CANCER; SPONTANEOUS ABORTION; SYNOSTOSIS; TUMOR VOLUME; ULCER; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; FIBROMATOSIS, AGGRESSIVE; HUMANS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960174836     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22916     Document Type: Article

References (32)

1. Dahn I, Jonsson N, Lundh G. Desmoid tumours. A series of 33 cases. Acta Chir Scand 1963;126:305-314.
2. Reitamo JJ, Hayry P, Nykyri E, et al. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77:665-673.
3. Ballo MT, Zagars GK, Pollack A, et al. Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999;17:158-167.
4. Wong SL. Diagnosis and management of desmoid tumors and fibrosarcoma. J Surg Oncol 2008;97:554-558.
5. Guadagnolo BA, Zagars GK, Ballo MT. Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys 2008;71:441-447.
6. Zlotecki RA, Scarborough MT, Morris CG, et al. External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 2002;54:177-181.
7. Merchant NB, Lewis JJ, Woodruff JM, et al. Extremity and trunk desmoid tumors. A multifactorial analysis of outcome. Cancer 1999;86:2045-2052.
8. Kingston CA, Owens CM, Jeanes A, et al. Imaging of desmoid fibromatosis in pediatric patients. AJR Am J Roentgenol 2002;178:191-199.
9. Kotiligam D, Lazar AJ, Pollock RE, et al. Desmoid tumor: A disease opportune for molecular insights. Histol Histopathol 2008;23:117-126.
10. Mendenhall WM, Zlotecki RA, Morris CG, et al. Aggressive fibromatosis. Am J Clin Oncol 2005;28:211-215.
11. Sakorafas GH, Nissotakis C, Peros G. Abdominal desmoid tumors. Surg Oncol 2007;16:131-142.
12. Sturt NJ, Clark SK. Current ideas in desmoid tumours. Fam Cancer 2006;5:275-285.
13. Schlemmer M. Desmoid tumors and deep fibromatoses. Hematol Oncol Clin North Am 2005;19:565-571.
14. Goldblum JR, Fletcher JA. Desmoid-type fibromatoses. In: Fletcher CDM, Unni KK, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone: World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer Press; 2002. 83-84.
15. Posner MC, Shiu MH, Newsome JL, et al. The desmoid tumor. Not a benign disease. Arch Surg 1989;124:191-196.
16. Spear MA, Jennings LC, Mankin HJ, et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40: 1998; 637-645.
17. Nuyttens JJ, Rust PF, Thomas CR, Jr., et al. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer 2000;88:1517-1523.
18. Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol 2007;25:1785-1791.
19. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution. J Clin Oncol 2003;21:1390-1397.
20. Buitendijk S, van de Ven CP, Dumans TG, et al. Pediatric aggressive fibromatosis: A retrospective analysis of 13 patients and review of literature. Cancer 2005;104:1090-1099.
21. Merchant TE, Nguyen D, Walter AW, et al. Long-term results with radiation therapy for pediatric desmoid tumors. Int J Radiat Oncol Biol Phys 2000;47:1267-1271.
22. Faulkner LB, Hajdu SI, Kher U, et al. Pediatric desmoid tumor: Retrospective analysis of 63 cases. J Clin Oncol 1995;13:2813-2818.
23. Jabbari S, Andolino D, Weinberg V, et al. Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy. Int J Radiat Oncol Biol Phys 2009;75:177-182.
24. Kamath SS, Parsons JT, Marcus RB, et al. Radiotherapy for local control of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 1996;36:325-328.
25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
26. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0, DCTD, NCI, NIH, DHHS. 2006.
27. Hosalkar HS, Torbert JT, Fox EJ, et al. Musculoskeletal desmoid tumors. J Am Acad Orthop Surg 2008;16:188-198.
28. Meazza C, Bisogno G, Gronchi A, et al. Aggressive fibromatosis in children and adolescents: The Italian experience. Cancer 2010;116:233-240.
29. Hase JC, Ainamo J, Etemadzadeh H, et al. Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. J Clin Periodontol 1995;22:533-539.
30. Skapek SX, Ferguson WS, Granowetter L, et al. Vinblastine and methotrexate for desmoid fibromatosis in children: Results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol 2007;25:501-506.
31. Lazar AJ, Hajibashi S, Lev D. Desmoid tumor: From surgical extirpation to molecular dissection. Curr Opin Oncol 2009;21:352-359.
32. Lazar AJ, Tuvin D, Hajibashi S, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 2008;173:1518-1527.